Orchid Pharma Limited — Call Transcript 2026

May 19, 2026

May 19, 2026

==> picture [552 x 66] intentionally omitted <==

National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai- 400051 Dalal Street, Fort, Mumbai- 400001

Symbol: ORCHPHARMA

Scrip Code: 524372

Ref: (i) Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

(ii)SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026

Sub: Intimation of schedule of Analysts/ Investors Earning Call for the QuarterIV and Financial Year ended on March 31, 2026

Dear Sir/Madam,

In reference to the captioned subject and pursuant to Regulation 30 read with Sub-Para 15, Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and in continuation to our intimation dated May 19, 2026 regarding intimation of schedule of Board Meeting, this is to intimate that an Analysts/Investors Earning Call hosted by ‘Systematix Institutional Equities’ is scheduled to be held on Tuesday, May 26, 2026 at 04:30 P.M. (IST) to discuss the financial results/ performance of the Company for the Quarter-IV and Financial Year ended on March 31, 2026.

The aforesaid information will also be hosted on the Company’s website at www.orchidpharma.com

Note: The schedule may undergo change due to exigencies on the part of the Analysts/Investors/Company and will be informed, if so.

The invite of the Analysts/Investors Earning Call is enclosed herewith.

You are requested to take the above intimation on record.

Thanking You, For Orchid Pharma Limited

KAPIL DAYYA

Digitally signed by KAPIL DAYYA DN: c=IN, st=Uttar Pradesh, 2.5.4.20=ab829c22de1effbdfc0b22c1656149c2ef30e6aef4e71d29529c889286e22c52, postalCode=201017, street=SO DEVENDRA SINGH FLAT NO202 BLOCKE AJNARA INTEGRITY RAJ NAGAR EXTENSION PO RAJ NAGAR EXTENSION DISTGHAZIABAD UTTAR PRADESH201017, pseudonym=ef66097a-543a-4978-9b6b-8c41cab206e9, serialNumber=e27acd3bad231a5f6fbc79a89feead642f7b38cfefea6c40cc3f8a9ba46b16ed, o=Personal, cn=KAPIL DAYYA Date: 2026.05.19 15:02:50 +05'30'

Kapil Dayya Company Secretary & Compliance Officer Mem. No. F10698

Encl.: as above

==> picture [519 x 12] intentionally omitted <==

Orchid Pharma Limited Regd. Office: Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu Dist.- 603110, Tamil Nadu, India Phone : (91)-44- 2744 4471/72/73 Email: Corporate@orchidpharma.com Website : www.orchidpharma.com CIN: L24222TN1992PLC022994

==> picture [183 x 51] intentionally omitted <==

SYSTEMATIX INSTITUTIONAL EQUITIES

Invites you to participate in

Q4FY26 Results Conference Call of

==> picture [131 x 43] intentionally omitted <==

Orchid Pharma Limited

On Tuesday, 26[th] May 2026 at 4:30 PM (IST)

The management will be represented by

Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta	Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta
Managing Director Whole Time Director Chief Financial Officer
Dial-in-number
Location Dial Number	Location Toll Free Number
Primary Number +91 22 6280 1297	USA :1 866 746 2133
	UK :0 808 101 1573
Secondary Number +91 22 7115 8198	Singapore :800 101 2045
	Hong Kong :800 964 448

Click here for your Diamond Pass™

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1885048&linkSecurityString=fb683d8b8 DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.

For more information, please contact:

Vishal Manchanda

Equity Research Analyst Contact No: +91 97374 37148 vishalmanchanda@systematixgroup.in

Mrunal Pawar

Senior VP & Group Head - Corporate Access & Corporate Communication Contact No: + 91 22 6704 8088 mrunalpawar@systematixgroup.in